We found that CEP55 is a downstream effector of MAPK signaling through MYC oncogene (Fig 7F), which has a central role in transformation, tumorigenesis, and genomic instability, and MYC is deregulated in many cancers (Sears et al, 2000; Prochownik, 2008). Here, CEP55 is linked to cancer.